hydrogen sulfide has been researched along with concanavalin a in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Chen, K; Cheng, P; Dai, W; Guo, C; Li, J; Lu, J; Shen, M; Wang, C; Wang, F; Wang, J; Xia, Y; Yang, J; Zhang, H; Zhang, Y; Zheng, Y; Zhou, Y; Zhu, R | 1 |
Chang, L; Dai, T; Ma, B; Ma, F; Mao, Y; Mei, Q; Shen, Z; Wang, Z; Xin, X; Zhu, Y | 1 |
2 other study(ies) available for hydrogen sulfide and concanavalin a
Article | Year |
---|---|
Hydrogen sulfide, a potential novel drug, attenuates concanavalin A-induced hepatitis.
Topics: Acute Disease; Animals; Apoptosis; Autophagy; Concanavalin A; Dose-Response Relationship, Drug; Hepatitis; Hydrogen Sulfide; Injections, Intravenous; Male; Mice; Mice, Inbred BALB C; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction | 2014 |
Topics: Animals; Chemical and Drug Induced Liver Injury, Chronic; Concanavalin A; Cysteine; Cytokines; Hydrogen Sulfide; Mice; Neurodegenerative Diseases | 2022 |